Breaking News
April 22, 2019 - Hyaline fibromatosis syndrome – Genetics Home Reference
April 22, 2019 - Scientists use CRISPR for possible ‘bubble boy’ therapy
April 22, 2019 - Hematologist (and a mom, singer, actress and much more) stands up for diversity
April 22, 2019 - Novel AI voice tool can help diagnose PTSD
April 22, 2019 - Overlooked part of cell’s internal machinery may hold key to treating acute myeloid leukemia
April 22, 2019 - MIT scientists reverse some behavioral symptoms of rare neurodevelopmental disorder
April 22, 2019 - Scientists find new therapy target for drug-induced liver failure
April 22, 2019 - Opioid dose variability could lead to increased risk of overdose, study suggests
April 22, 2019 - Newly developed model predicts salmonella outbreaks several months in advance
April 22, 2019 - Deep-learning model better predicts survival outcomes for lung cancer
April 22, 2019 - One in Three U.S. Adults Aged 35 to 44 May Have Drinking Problem
April 22, 2019 - Why the measles virus is so contagious
April 22, 2019 - Magnet ‘Zap’ to the Brain Might Jumpstart Aging Memory
April 22, 2019 - Immune response to gut microbes may be early indicator of type 1 diabetes
April 22, 2019 - Destination Limbo: Health Suffers Among Asylum Seekers In Crowded Border Shelter
April 22, 2019 - Research shows how dopamine contributes to sex differences in worms
April 22, 2019 - Marijuana users weigh less compared to non-users
April 22, 2019 - Research uncovers critical RNA processing aberrations in ALS and FTD
April 22, 2019 - Many cancer patients use marijuana and prescription opioids, study reveals
April 22, 2019 - Frailty may up fracture risk in patients with type 2 diabetes
April 22, 2019 - Study provides new insight into how obesity, insulin resistance can affect cognition
April 22, 2019 - Study seeks to better understand the genetic causes for hypospadias
April 22, 2019 - FDA grants approval of first generic naloxone nasal spray to treat opioid overdose
April 22, 2019 - FDA authorizes marketing of first medical device to treat ADHD
April 22, 2019 - Vanderbilt researchers to develop and test ‘safe harbor’ standards of care
April 22, 2019 - You’re probably brushing your teeth wrong – here are four tips for better dental health
April 22, 2019 - Pharmacy closures contribute to medication non-adherence among heart patients
April 22, 2019 - Using Edge AI technology to observe behavior of cattle
April 22, 2019 - Bacteria play a role in the development of stomach ulcers in pigs
April 22, 2019 - Hand Hygiene Compliance Poor in Task Transitions
April 22, 2019 - smoking could harm your baby
April 22, 2019 - Scientists identify rare, paradoxical response to antiretroviral therapy
April 21, 2019 - More TV, Tablets, More Attention Issues at Age 5
April 21, 2019 - Drug reduces risk of kidney failure in people with diabetes, study finds
April 21, 2019 - New research identifies novel link between antibiotic resistance and climate change
April 21, 2019 - Simple intervention can provide lasting protection for teens against junk food marketing
April 21, 2019 - The protein p38-gamma identified as a new therapeutic target in liver cancer
April 21, 2019 - Novel system enables researchers to study bacteria within mini-tissues in a dish
April 21, 2019 - Discovery of oral cancer biomarkers could save thousands of lives
April 21, 2019 - Geneva Exhibition committee gives gold medals to two medications developed by Kazan
April 21, 2019 - Scientists aim to minimize or eliminate hair loss during cancer treatment
April 21, 2019 - WiFi interacts with signaling pathways in the human brain
April 21, 2019 - Stroke Hospitalizations Down in Black, White Medicare Enrollees
April 21, 2019 - First common risk genes discovered for autism
April 21, 2019 - Researchers map auditory sensory system of the mouse brain
April 21, 2019 - Scientists Bring Pig’s Brain, Dead 4 Hours, Back to ‘Cellular Activity’
April 21, 2019 - Virtual reality a promising tool for reducing fears and phobia in autism
April 21, 2019 - New analysis lists out opportunities for U.S. medical schools to advance population health
April 21, 2019 - More sleep may help teens with ADHD focus and organize
April 21, 2019 - Breakthrough antibody treatment suppresses HIV without antivirals
April 21, 2019 - AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA) Type 1
April 21, 2019 - Is your hand pain arthritis, carpal tunnel or something else?
April 21, 2019 - Measles outbreaks may become more frequent if vaccination rates continue to decline
April 21, 2019 - Researchers succeed in accelerating process of creating 3D images
April 21, 2019 - Tiny worm mimics key genetic risk for Alzheimer’s
April 21, 2019 - Angry dreams explained by brain waves
April 20, 2019 - Parenteral Antimicrobial Tx at Home Burdens Children’s Caregivers
April 20, 2019 - Diabetes treatment may keep dementia, Alzheimer’s at bay
April 20, 2019 - New bandage-like biosensor collects and analyzes sweat
April 20, 2019 - A comprehensive, centralized database of bovine milk compounds
April 20, 2019 - Two new epigenetic regulators maintain self-renewal of embryonic stem cells
April 20, 2019 - New Evidence That Veggies Beat Steak for Heart Health
April 20, 2019 - Study reveals genes associated with heavy drinking and alcoholism
April 20, 2019 - Texas A&M AgriLife becomes the newest member of NutriRECS international consortium
April 20, 2019 - In most states, insurance won’t cover addiction treatments
April 20, 2019 - Computer-based memory games may be beneficial for individuals with fragile X syndrome
April 20, 2019 - Timing of food intake influences molecular clock in the liver of mice
April 20, 2019 - Precise decoding of breast cancer cells paves way for new treatment option
April 20, 2019 - Scientists use 3D imaging to help model complex processes performed by placenta
April 20, 2019 - MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
April 20, 2019 - Genetic variants that protect against obesity could aid new weight loss medicines
April 20, 2019 - New technology developed for microscopic imaging in living organisms
April 20, 2019 - when quitting cigarettes, consider using more nicotine, not less
April 20, 2019 - Key proteins can block Listeria without triggering the death of host cells
April 20, 2019 - Researchers create a working model of cerebral tract to study brain function
April 20, 2019 - New study shows that microbes can help break toxic chemical in dust
April 20, 2019 - Scientists use NIR light and injected DNA nanodevice to guide stem cells to injury
April 20, 2019 - Microbial Features ID’d for Pediatric Irritable Bowel Syndrome
April 20, 2019 - Study reveals patterns of drug intoxication deaths, organ donors across the US
April 20, 2019 - Scientists deploy CRISPR gene-editing tool to engineer multiple edits
Finding the elusive drinking ‘brake’

Finding the elusive drinking ‘brake’

image_pdfDownload PDFimage_print
Finding the elusive drinking ‘brake’
Credit: UC Santa Barbara

It’s a common scene in bars and clubs: messy, falling-down drunk, slurring and incoherent, precariously close to catastrophe … and asking the bartender for another shot.

For the majority of us who imbibe, there is a certain point at which we stop pounding the drinks, and many reasons we do so. Maybe we sense that we’re close to our limit, or we notice we don’t feel as well—physically and emotionally—as we did a couple of glasses ago. And sometimes the sedative effects of the alcohol just take over. But for a certain subset of people, nothing—not the risk of losing control or the threat of nausea and dizziness—is enough to put the brakes on their drinking.

UC Santa Barbara neuroscientist Karen Szumlinski, who investigates binge drinking and the repeated stress of overdrinking on the brain, suggests a neurobiological mechanism might underpin this behavior. She and her team have uncovered a mechanism in a small brain structure called the bed nucleus of the stria terminalis (BNST) that helps sense alcohol’s negative effects and modulates the urge to drink. When it doesn’t function properly, however, we lose the ability to perceive when we’ve had enough—or, perhaps, one too many—and we continue to drink.

“If a little bit of intoxication is making you nervous, the BNST is doing its job,” said Szumlinski, a co-author of a paper that appears in the Journal of Neuroscience.

An adaptive response to limit alcohol consumption

The urge for us to do virtually anything comes from signals that loop in and around our brains in areas that govern our perceptions, emotions and desires. These in turn connect to our motor functions and create behaviors. This process involves a complex set of signaling pathways, involving many neurotransmitters, as well as their associated proteins and receptors. Those examined in this study are specific to an area of the brain highly implicated in the interface between anxiety and motivation—the BNST, which is connected to, among other things, both the amygdala (which modulates fear and anxiety), and the nucleus accumbens (reward, aversion, motivation).

In previous studies, the researchers found that binge drinking elevates several aspects of signaling through the excitatory neurotransmitter glutamate in both the amygdala and the nucleus accumbens. Using a variety of experimental approaches, they also showed that this increased glutamate signaling drove excessive drinking. Along with the BNST, these regions form a subcircuit in the brain known as the extended amygdala.

“So in the amygdala the increased glutamate signaling is going to possibly generate negative emotions, and maybe you start feeling depressed or anxious, and then that will translate to a higher motivation to drink coming out of the nucleus accumbens,” Szumlinski said. Alcoholism—addiction in general—is a shifting target that moves between the motivation toward the “feel-good” effects of the drug and motivation to avoid the unpleasant withdrawal symptoms or to simply feel normal again after the dependency has been established.

The researchers initially presumed that because the BNST is connected to both structures, the function of high glutamate signaling in the BNST is similar to that of the nucleus accumbens and the amygdala. But instead they found it contains a “brake” mechanism, an adaptive response to limit alcohol consumption. And pumping that pedal is a scaffolding protein called Homer2.

As it turns out, Homer2’s effects on the amygdala and nucleus accumbens are opposite to those in the BNST.

“When we manipulated Homer2 (in mouse models)—when we knocked it down in the amygdala or the accumbens—the animals stopped binge drinking,” Szumlinski said. When they reduced the expression of Homer2 in the BNST, however, the animals binge drank more. And according to Szumlinski, a lot more.

“We know that the ability of Homer2 to interact with the glutamate receptors (mGlu5) can be regulated in a number of ways,” she continued. “And so we wanted to know: What other part(s) of the signaling pathway is interacting with Homer2, and how might that be contributing to the brake process in the BNST?”

They found their answer in an enzyme. Extracellular signal-regulated kinase (ERK, for short) is another of the usual suspects in the realm of addictive disorders. In a mouse model that carried a mutation in its mGlu5 receptors resulting in their inability to be activated by ERK, the researchers found that the mutation had an unexpectedly significant impact on alcohol preference and consumption.

“Based on the available biochemical information at the time we started testing the mGlu5 mutant mice, we predicted a minimal impact on any behavior,” Szumlinski said. The receptor still worked, it just wasn’t sensitive to ERK, she explained. “But there was a huge impact on drinking behavior in a direction opposite to what we predicted.” The mutant mice instead exhibited strong preferences for environments in which they experienced the effects of high-dose alcohol (doses that normal mice find aversive) and the mice consumed large amounts of high-dose alcohol under a number of different drinking procedures.

“So it really showed that something’s going on when you drink alcohol,” she said of this brake in the BNST. “You’re activating this enzyme ERK, which would normally phosphorylate the mGlu5 receptor, and help Homer2 bind better. All of this together serves as a brake to reduce or at least curb your alcohol consumption. But if any kink happens in that little bit of signaling there, you lose the brakes. Your brake line has been cut, and now you exhibit uncontrolled drinking behavior.”

Flying in the face of accepted notions

While all that is occurring in brain behaviorally, tampering with the BNST also seems to shut down or interfere with the typical aversive feedback that would normally prompt the drinker to stop—perhaps the nausea, dizziness, lack of control. Interestingly, Szumlinski added, messing with ERK-mGlu5 signaling also makes an animal overtly more drunk: compared to normal mice, the mGlu5 mutants studied lost their motor coordination on low doses of alcohol and they remained asleep longer when administered higher alcohol doses. Typical mice find increased alcohol sensitivity aversive. However, the mGlu5 mutants are falling-over drunk to observers, but they seem to interpret their situation as just fine.

It’s a jump to link the behavior of drunk lab mice and drunk people, noted Szumlinski, but there are connections that can be made in the array of complex brain processes that drive alcoholism.

“How we perceive how drunk we are is going to influence our subsequent drinking,” Szumlinski said. “Although their behavior is telling us they are completely intoxicated, maybe they don’t feel hammered. Or maybe when they’re feeling drunk, they don’t perceive that as a bad thing. Their awareness of their intoxicated state does not line up with their high-dose alcohol preference or their drinking behavior. And so presumably that might have something to do with BNST glutamate function.”

These results fly in the face of the widely accepted notion that one’s sensitivity to alcohol dictates their likelihood of drinking, Szumlinksi said.

“There’s a lot of literature, including lots of human data, that says if you are more sensitive to the intoxicating effects of alcohol, you are less likely to drink,” Szumlinski said. “We see this is in the genetic literature with people who have the various different enzyme mutations. Examples of these sensitivities are demonstrated in, among other reactions, the flushing, headaches or nasal congestion that happens for some people when they consume alcohol.

“This study says you can be incredibly sensitive to the intoxicating effects of alcohol, but that doesn’t necessarily feed back on you the way it should,” she continued. “And, presumably, the ability of that intoxication to signal to your body: ‘Hey, stop drinking,’ is somehow regulated by the BNST. The big questions now are: What is the identity of the neural circuit containing the BNST that allows the brakes to engage and how do ‘bad BNST brakes’ relate to Alcohol Use Disorder in the human condition?”


Modulating stress circuits


More information:
Rianne R. Campbell et al. Increased alcohol-drinking induced by manipulations of mGlu5 phosphorylation within the bed nucleus of the stria terminalis, The Journal of Neuroscience (2019). DOI: 10.1523/JNEUROSCI.1909-18.2018


Provided by
University of California – Santa Barbara

Citation:
Finding the elusive drinking ‘brake’ (2019, February 21)
retrieved 26 March 2019
from https://medicalxpress.com/news/2019-02-elusive.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Tagged with:

About author

Related Articles